Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effective dose of ciprofol with alfentanil for deep sedation in fiberoptic bronchoscopy
ChiCTR2200061131Phase 4Recruiting
- Sponsor
- Weifang People's Hospital
- Start
- Jun 2022
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ciprofol in bronchopulmonary diseases (2 arms), sponsored by Weifang People's Hospital. Primary endpoint: Effective dose. Started Jun 2022; status: recruiting.
02
Drugs
ciprofol
03
Conditions
bronchopulmonary diseases
Beyond the preview
Go deeper on ChiCTR2200061131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061131.